Earnings Neutral

Brown & Brown, Inc. acquires the assets of Tire Shield

Breaking news from global financial markets

2 months ago
Read More
Brown & Brown, Inc. acquires the assets of Tire Shield

Brown & Brown, Inc. acquires the assets of Tire Shield

Earnings
2 months ago 4,075
Read More
VTV Therapeutics Inc-CL A (NASDAQ:VTVT) Reports Wider Q2 2025 Loss Amid Clinical-Stage Progress

VTV Therapeutics Inc-CL A (NASDAQ:VTVT) Reports Wider Q2 2025 Loss Amid Clinical-Stage Progress

Earnings
2 months ago 3,050
Read More
ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss

ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss

Earnings
2 months ago 2,364
Read More
Rekor Systems Inc (NASDAQ:REKR) Q2 2025 Earnings: Revenue Misses, EPS Narrower Than Expected

Rekor Systems Inc (NASDAQ:REKR) Q2 2025 Earnings: Revenue Misses, EPS Narrower Than Expected

Earnings
2 months ago 2,202
Read More
Venture Global wins arbitration case against Shell over contracted LNG cargoes

Venture Global wins arbitration case against Shell over contracted LNG cargoes

Earnings
2 months ago 2,420
Read More
Venture Global wins arbitration case against Shell over contracted LNG cargoes

Venture Global wins arbitration case against Shell over contracted LNG cargoes

Earnings
2 months ago 4,608
Read More
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) Reports Q2 2025 Wider Loss but Extends Cash Runway with Strategic Restructuring

ORIC Pharmaceuticals Inc (NASDAQ:ORIC) Reports Q2 2025 Wider Loss but Extends Cash Runway with Strategic Restructuring

Earnings
2 months ago 3,827
Read More
OnKure Therapeutics Inc-A (NASDAQ:OKUR) Reports Q2 2025 Earnings Beat with Narrower-Than-Expected Loss

OnKure Therapeutics Inc-A (NASDAQ:OKUR) Reports Q2 2025 Earnings Beat with Narrower-Than-Expected Loss

Earnings
2 months ago 3,425
Read More
Editas Medicine Inc (NASDAQ:EDIT) Reports Mixed Q2 2025 Earnings: Revenue Beat but Wider Loss

Editas Medicine Inc (NASDAQ:EDIT) Reports Mixed Q2 2025 Earnings: Revenue Beat but Wider Loss

Earnings
2 months ago 887
Read More
Astria Therapeutics Inc (NASDAQ:ATXS) Reports Narrower-Than-Expected Q2 2025 Loss and Strong Cash Runway

Astria Therapeutics Inc (NASDAQ:ATXS) Reports Narrower-Than-Expected Q2 2025 Loss and Strong Cash Runway

Earnings
2 months ago 3,375
Read More
Meritage Reports Second Quarter 2025 Results; New Products & Innovation Cycle Ahead

Meritage Reports Second Quarter 2025 Results; New Products & Innovation Cycle Ahead

Earnings
2 months ago 2,841
Read More
Meritage Reports Second Quarter 2025 Results; New Products & Innovation Cycle Ahead

Meritage Reports Second Quarter 2025 Results; New Products & Innovation Cycle Ahead

Earnings
2 months ago 4,281
Read More
Logan Energy GAAP EPS of C$0.03, revenue of C$41.99M

Logan Energy GAAP EPS of C$0.03, revenue of C$41.99M

Earnings
2 months ago 1,341
Read More
Metagenomi Inc (NASDAQ:MGX) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected

Metagenomi Inc (NASDAQ:MGX) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected

Earnings
2 months ago 1,583
Read More
INOVIO PHARMACEUTICALS INC (NASDAQ:INO) Reports Q2 2025 Results: Revenue at $0.0, EPS Loss of $0.61 Amid 4.7% After-Hours Drop

INOVIO PHARMACEUTICALS INC (NASDAQ:INO) Reports Q2 2025 Results: Revenue at $0.0, EPS Loss of $0.61 Amid 4.7% After-Hours Drop

Earnings
2 months ago 2,319
Read More
CAVA GROUP INC (NYSE:CAVA) Reports Mixed Q2 2025 Results with Revenue Miss and EPS Beat

CAVA GROUP INC (NYSE:CAVA) Reports Mixed Q2 2025 Results with Revenue Miss and EPS Beat

Earnings
2 months ago 1,236
Read More
Atlassian CEO Cannon-Brookes sells $1.25 million in stock

Atlassian CEO Cannon-Brookes sells $1.25 million in stock

Earnings
2 months ago 1,847
Read More
Electro-Sensors GAAP EPS of $0.02, revenue of $2.4M

Electro-Sensors GAAP EPS of $0.02, revenue of $2.4M

Earnings
2 months ago 1,942
Read More
Marchex Inc. (NASDAQ:MCHX) Reports Mixed Q2 2025 Results with Revenue Miss and Adjusted EBITDA Growth

Marchex Inc. (NASDAQ:MCHX) Reports Mixed Q2 2025 Results with Revenue Miss and Adjusted EBITDA Growth

Earnings
2 months ago 4,943
Read More

Trending Now

1

ROSEN, LEADING INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors...

37,012 34 minutes ago
2

Kaltura signals transition to AI-driven CX/EX with eSelf acquisition and targets...

43,388 36 minutes ago
3

Apei outlines $640M-$644M full-year revenue target as enrollment momentum drives...

15,674 36 minutes ago
4

Lexington Law Firm Named Best Credit Repair Company of 2026 Reviews by Tidewater...

19,391 42 minutes ago
5

Amid Trillion-Dollar Package Criticism, Elon Musk Reveals He Came To Montreal Wi...

49,650 48 minutes ago

Trending Topics

Sentiment (24h)

Positive
1207
Neutral
403
Negative
346